secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2026-06-25T20:32:25+00:00
Accession:  0001193125-26-282873
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum stockholders elect three Class I directors, approve advisory compensation, ratify auditor
--------------------------------------------------------------------------------

- Sonja Banks, Alan Ezekowitz, Colin Hill elected as Class I directors for three-year terms ending 2029.
- Advisory vote on named executive officer compensation approved with 50.7M for, 3.0M against.
- Ratification of Ernst & Young as FY2026 auditor approved with 58.8M for, 36K against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/0001193125-26-282873-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312526282873/d159102d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-282873

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer